Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 11 sales; 290 institutions reported holding it in 13F filings for Q3 2026, worth $1.66B in total; no superinvestor holds it.
Holders of 5% or more of ANIP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ani Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 12.80%2.90M shares | +1.50 ppfrom 11.30% | Oct 17, 20252 filings | Jul 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
24 Schedule 13D and 13G filings on Ani Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G/A | 12.80%2.90M shares | +1.50 ppfrom 11.30% | Jun 30, 2026 | SEC |
| Mar 26, 20263:46 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 13, 20254:28 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 0.30%65.2K shares | −4.90 ppfrom 5.20%Below 5% | Sep 30, 2025 | SEC |
| Oct 17, 20256:05 PM ET | BlackRock, Inc. | 13G/A | 11.30%2.52M shares | – | Sep 30, 2025 | SEC |
| Aug 22, 20258:00 AM ET | Meridian Venture Partners II GP, L.P.and 3 others | 13D/A | 4.80%1.03M shares | −0.60 ppfrom 5.40%Below 5% | Aug 21, 2025 | SEC |
| Jun 4, 20254:00 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.20%1.12M shares | New | May 30, 2025 | SEC |
| Apr 10, 20254:00 PM ET | Millennium Management LLCand 2 others | 13G/A | 3.80%818.3K shares | −1.40 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| Mar 13, 20258:50 PM ET | Meridian Venture Partners II GP, L.P.and 3 others | 13D/A | 5.40%1.18M shares | – | Mar 11, 2025 | SEC |
| Jan 21, 20254:04 PM ET | Millennium Management LLCand 2 others | 13G | 5.20%1.09M shares | New | Jan 14, 2025 | SEC |
| Nov 13, 2024 | Rubric Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Mar 14, 2024 | Meridian Venture Partners II GP, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2024 | Rubric Capital Management LP | 13GOld format | – | New | – | SEC |
| Jan 23, 20244:13 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 17, 2024 | Esjay LLC | 13D/AOld format | – | – | – | SEC |
| Dec 18, 2023 | Meridian Venture Partners II GP, L.P. | 13D/AOld format | – | – | – | SEC |
| Dec 5, 2023 | Esjay LLC | 13D/AOld format | – | – | – | SEC |
| Aug 18, 2023 | Meridian Venture Partners II GP, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 26, 20238:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20239:43 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Dec 12, 2022 | Meridian Venture Partners II GP, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 2, 2022 | Esjay LLC | 13DOld format | – | New | – | SEC |
| Feb 7, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20216:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
106 notices from officers, directors and other affiliates planning to sell Ani Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20264:45 PM ET | Nikhil LalwaniDirector · Officer | 5.40K | $385.8K | Nov 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 29, 20264:20 PM ET | Stephen CareyOfficer | 8.55K | $613.1K | Oct 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 15, 20264:25 PM ET | Nikhil LalwaniDirector · Officer | 5.40K | $378.9K | Oct 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 15, 20264:24 PM ET | Nikhil LalwaniDirector · Officer | 5.40K | $380.2K | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 11, 20264:33 PM ET | Jeanne ThomaDirector | 1.00K | $71.5K | Sep 11, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 25, 20264:42 PM ET | Nikhil LalwaniDirector · Officer | 5.40K | $400.5K | Aug 25, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 29, 20264:21 PM ET | Stephen P CareyOfficer | 6.16K | $499.4K | Jul 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 7, 20264:04 PM ET | Patrick WalshDirector | 4.34K | $373.7K | Jul 7, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 8, 20264:36 PM ET | Thomas HaugheyDirector | 2.00K | $162.2K | Jun 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 5, 20264:48 PM ET | Stephen P CareyOfficer | 11.9K | $939.5K | Jun 5, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 13, 202611:04 AM ET | Walsh Patrick DDirector | 10.0K | $795.6K | May 13, 2026 | Charles Schwab Corp | SEC |
| May 11, 20266:34 PM ET | Nikhil LalwaniOfficer · Director | 55.0K | $4.27M | May 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 11, 20264:51 PM ET | Patrick WalshDirector | 3.97K | $320.8K | May 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 5, 20265:22 PM ET | Stephen P CareyOfficer | 7.31K | $552.0K | Mar 5, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 3, 20264:24 PM ET | Patrick WalshDirector | 6.00K | $445.4K | Mar 3, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 9, 20255:12 PM ET | Renate Plawner Tannenbaum 2024 RV TrustDirector | 1.80K | $146.1K | Dec 5, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 13, 20254:48 PM ET | Patrick WalshDirector | 8.64K | $750.9K | Nov 13, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 3, 20254:03 PM ET | Antonio R PeraDirector | 7.29K | $692.3K | Sep 3, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 25, 20255:00 PM ET | Matthew LeonardDirector | 2.53K | $229.1K | Aug 25, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 21, 20254:26 PM ET | Shanmugam MuthusamyOfficer | 53.0K | $4.79M | Aug 21, 2025 | Merrill Lynch | SEC |
| Aug 20, 20254:58 PM ET | Shanmugam MuthusamyOfficer | 47.0K | $4.24M | Aug 20, 2025 | Merrill Lynch | SEC |
| Aug 20, 20254:02 PM ET | Antonio R PeraDirector | 5.42K | $486.4K | Aug 20, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 19, 20255:47 PM ET | Jeanne ThomaDirector · 10% stockholder | 14.7K | $1.30M | Aug 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 18, 20254:19 PM ET | Jeanne A ThomaDirector | 6.87K | $616.2K | Aug 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 18, 20254:18 PM ET | Matthew LeonardDirector | 6.94K | $611.6K | Aug 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the ANIP notices from the last 12 months